Fibromyalgia Clinical Trial
Official title:
Efficacy of Memantine in the Treatment of Fibromyalgia: a Double-blind Randomized Trial
Fibromyalgia (FM) is a chronic rheumatic disease of high prevalence and great clinical
impact. However, the treatment for FM has limited efficacy, with an effect size of about
0.5. Recent studies have found raised levels of glutamate in the insula, hippocampus and
posterior cingulate cortex regions of the brain. This has led a number of authors to suggest
the usefulness of glutamate blocking drugs in the treatment of FM.
Aims: To evaluate the efficacy of memantine in the treatment of pain and other symptoms of
FM and to assess its efficacy in reducing brain glutamate levels in patients with FM.
Material and methods: Randomized controlled trial, of six months duration (including a dose
adjustment period of one month). 60 patients with FM will be recruited for inclusion in the
study upon fulfillment of selection criteria, and they will be randomized in two groups: A)
Treatment group (n=30), will receive 20 mg of memantine o.d ; B) Control group (n=30) will
receive placebo. The main objective is to assess the efficacy of memantine in the treatment
of pain (pain threshold, pain perception) and other symptoms in fibromyalgia (cognitive
state, health status, state of anxiety and depression, quality of life and perceived
improvement. Discussion: There is a need for the development of innovative and more
effective alternatives for the treatment of FM. This clinical trial will determine whether
memantine can be considered as an option in the treatment of FM patients.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05659862 -
Digitally Assisted Behavioral Physical Activity Intervention in Fibromyalgia
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT03042728 -
Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program
|
N/A | |
Recruiting |
NCT06097091 -
Effects and Mechanisms of Pain Neuroscience Education in Patients With Fibromyalgia
|
N/A | |
Recruiting |
NCT04554784 -
Effectiveness of Bowen Therapy for Pain Management in Patients With Fibromyalgia
|
N/A | |
Completed |
NCT03300635 -
Metabolism, Muscle Function and Psychological Factors in Fibromyalgia
|
N/A | |
Recruiting |
NCT06166563 -
Exercise, Irritable Bowel Syndrome and Fibromyalgia
|
N/A | |
Completed |
NCT03166995 -
Postural Exercises in Women With Fibromyalgia
|
N/A | |
Completed |
NCT03227952 -
Sensory Stimulation in Fibromyalgia
|
N/A | |
Recruiting |
NCT06237595 -
Vagus Nerve Stimulation in Fibromyalgia
|
N/A | |
Completed |
NCT01888640 -
Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST)
|
N/A | |
Completed |
NCT03641495 -
Pain Education and Therapeutic Exercise for Fibromyalgia
|
N/A | |
Recruiting |
NCT05581628 -
FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE
|
||
Active, not recruiting |
NCT05128162 -
Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia
|
Phase 2 | |
Completed |
NCT04674878 -
Comparison of Muscle Energy Techniques and Breathing Exercises for Functional Improvement in Fibromyalgia
|
N/A | |
Active, not recruiting |
NCT04084795 -
Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia
|
N/A | |
Completed |
NCT03129906 -
Impact of the Restriction of Sources of Gluten in Fibromyalgia Patients
|
N/A | |
Completed |
NCT05058911 -
Exposure-based Cognitive Behavior Therapy vs Traditional Cognitive Behavior Therapy for Fibromyalgia
|
N/A | |
Recruiting |
NCT04571853 -
New Educational Tool for FM
|
N/A | |
Recruiting |
NCT04571528 -
Effectiveness of VIRTUAL FIBROWALK STUDY
|
N/A |